Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

LSE:SAGA
LSE:SAGAInsurance

UK Growth Stocks With High Insider Ownership You Should Know About

As the UK market grapples with external pressures, notably from China's sluggish economic recovery impacting commodity prices and investor sentiment, the FTSE 100 and FTSE 250 indices have seen declines. In such challenging times, identifying growth companies with high insider ownership can be crucial as these stocks often indicate strong confidence from those closest to the company's operations, potentially offering resilience amid broader market volatility.
LSE:ATG
LSE:ATGConsumer Services

Discovering UK Penny Stocks: Auction Technology Group And Two More Picks

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 index dipping amid weak trade data from China, highlighting global economic interdependencies. Despite these fluctuations, investors often seek opportunities in lesser-known corners of the market. Penny stocks, though an older term, still hold relevance as they represent smaller or newer companies that can offer significant potential when backed by solid financials.
LSE:IGG
LSE:IGGCapital Markets

UK Dividend Stocks Featuring 3 Noteworthy Payers

In recent weeks, the UK market has faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and global economic uncertainties. As investors navigate these turbulent times, dividend stocks can offer a measure of stability and income potential in an otherwise volatile environment.
BIT:MOL
BIT:MOLConsumer Finance

Does Moltiply’s 2025 Results and New Dividend Payout Change The Bull Case For Moltiply Group (BIT:MOL)?

Moltiply Group S.p.A. recently reported full-year 2025 results, with sales of €695.89 million and net income of €28.59 million, and also declared an annual dividend of €0.15 per share payable on July 8, 2026, with an ex-date of July 6 and record date of July 7. The combination of higher sales but lower earnings per share, alongside a new cash dividend, highlights how Moltiply Group is balancing growth investments with shareholder returns. We’ll now examine how the earnings...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum Governance Vote And What It Could Mean For Valuation

Marathon Petroleum (NYSE:MPC) has scheduled a shareholder vote on a proposed amendment to its Certificate of Incorporation at the 2026 Annual Meeting. The proposal focuses on corporate governance terms that could influence shareholder rights and future decision making at the company. Investors will have the opportunity to review and vote on the amendment as part of the formal meeting agenda. Marathon Petroleum operates as a large US refiner and fuel marketer, so changes to its governance...
ENXTAM:DSFIR
ENXTAM:DSFIRChemicals

How Investors Are Reacting To DSM-Firmenich (ENXTAM:DSFIR) €540 Million Share Buyback And Capital Reduction

On March 12, 2026, DSM-Firmenich AG announced a share repurchase program of up to €540 million, with €500 million earmarked for capital reduction and €40 million to satisfy share-based compensation, to be executed by a mandated bank and targeted for completion by the end of Q3 2026. This sizable buyback authorization signals the Board’s willingness to return cash to investors while tightening the share count, which can meaningfully influence ownership dilution from employee equity plans and...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte Taps Kevin Haas To Guide AI Push And Undervalued Shares

Veracyte, NasdaqGM:VCYT, has appointed Kevin Haas, Ph.D., as Chief Development and Technology Officer in a newly created executive role. Dr. Haas will oversee assay development, software, AI, and next generation informatics across Veracyte's product pipeline. The move reflects Veracyte's focus on whole genome MRD and multi omics applications across its global portfolio. Veracyte's share price stands at $32.94, with a return of 60.1% over the past 3 years and a 2.2% decline over the past...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

How Investors Are Reacting To CVB Financial (CVBF) Beating Estimates While Affirming Its 2026 Dividend

CVB Financial Corp. recently approved a US$0.20 per share cash dividend for the first quarter of 2026, payable on or about April 15, 2026, to shareholders of record as of April 1, 2026. This dividend affirmation reinforces the bank’s emphasis on returning cash to shareholders even as its latest quarterly results exceeded analyst expectations on revenue, net interest income, and earnings per share. With this fresh dividend declaration as a backdrop, we’ll explore how CVB Financial’s latest...
NYSE:JAN
NYSE:JANHealth Care REITs

Janus Living Adds $600m Unsecured Credit To Support Future Growth Choices

Janus Living (NYSE:JAN) has arranged $600 million in new unsecured credit facilities. The package includes a $500 million unsecured revolving credit facility and a $100 million unsecured delayed draw term loan facility. The new funding is intended to increase liquidity and support future expansion plans. For investors watching NYSE:JAN, the new credit facilities arrive with the stock at $23.75 and a year-to-date return of 0.6%. The move reshapes Janus Living's funding options as a REIT and...
TSE:9449
TSE:9449IT

Assessing GMO Internet Group (TSE:9449) Valuation After GPU Cloud Alliance With Turing Inc.

Dividend cut and GPU cloud alliance put GMO internet group (TSE:9449) in focus GMO internet group (TSE:9449) has drawn fresh attention after announcing a reduced year end dividend, alongside a new capital and business alliance with Turing Inc. centered on the GPU cloud market. The dividend for the fourth quarter ended December 31, 2025 was set at ¥8.10 per share, compared with ¥10.00 a year earlier. The Turing Inc. agreement includes a share subscription and a 3.2 billion yen investment. See...
TASE:NVLG
TASE:NVLGHealthcare

Novolog (TASE:NVLG) Profitability Reliant On ₪4.5m One Off Gain In FY 2025 Q3

Novolog (Pharm-Up 1966) (TASE:NVLG) has reported its FY 2025 third quarter with revenue of ₪483.6 million and basic EPS of ₪0.0077, alongside net income excluding extra items of ₪4.0 million. The trailing 12 month figures show revenue of ₪1.97 billion and basic EPS of ₪0.0243. Over recent quarters, revenue has moved between ₪441.7 million and ₪689.9 million, while quarterly basic EPS has ranged from ₪0.0020 to ₪0.0260. This gives investors a clearer view of how headline growth is feeding...
NasdaqCM:PESI
NasdaqCM:PESICommercial Services

Perma Fix Environmental Services (PESI) Loss Narrows To US$0.10 EPS Challenging Bearish Narratives

Perma-Fix Environmental Services (PESI) FY 2025 earnings snapshot Perma-Fix Environmental Services (PESI) reported third quarter FY 2025 revenue of US$17.5 million with a basic EPS loss of US$0.10, while trailing twelve month EPS stood at a loss of US$0.64 on revenue of US$60.7 million. This highlights that the business remains in loss making territory. Over recent quarters, revenue has ranged from US$13.9 million to US$17.5 million, while quarterly EPS losses have moved between US$0.09 and...
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

Is AvePoint (AVPT) Offering A Long Term Opportunity After Recent Share Price Weakness

If you are wondering whether AvePoint's current share price lines up with its underlying worth, this breakdown will help you make sense of what the market is implying. The stock recently closed at US$9.61, with returns of 8.4% decline over 7 days, 8.5% decline over 30 days, 27.3% decline year to date, 36.9% decline over 1 year, 146.4% gain over 3 years, and 13.3% decline over 5 years, so the recent share price path has been mixed across different time frames. Recent news coverage has focused...